8-K
filed October 16, 2024, 7:59 PM ET
ticker LNAI
CIK 0001527728
leadership
confidence high
sentiment negative
materiality 0.85
Renovaro appoints new CEO David Weinstein; multiple board resignations including chairman
Lunai Bioworks Inc.
- David Weinstein (age 64) appointed CEO and board member; base salary $400k, up to $150k bonus, 250k restricted shares, 1.6M stock options.
- Former CEO Mark Dybul resigned Oct 12, 2024; eight directors resigned between Oct 11-15, including chairman Rene Sindlev.
- New directors appointed: Maurice van Tilburg, James McNulty, Douglas Calder, Mark Collins.
- Weinstein receives $25k bonus if company secures $2M+ in new financing; severance includes 6 months' salary and accelerated equity vesting.
- Resignations by James Sapirstein, Gregg Alton, Jayne McNicol, Carol Brosgart were by letters; no disagreements cited.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Avram Miller resigned as Director at Lunai Bioworks Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On October 11, 2024, Avram Miller resigned as a director on the Board of the Company, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Rene Sindlev resigned as Chairman of the Board at Lunai Bioworks Inc..
- Action
- resigned
- Role
- Chairman of the Board
Exact text from the filing
On October 15, 2024, Rene Sindlev resigned as the Chairman of the Board of the Company, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.5
David Weinstein was appointed as Director at Lunai Bioworks Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Gregg Alton resigned as Lead Independent Director at Lunai Bioworks Inc..
- Action
- resigned
- Role
- Lead Independent Director
Exact text from the filing
On October 13, 2024, Gregg Alton the Lead Independent Director on the Board, Jayne McNicol and Carol Brosgart formally advised the Board of the Company that they were resigning from the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.5
Douglas Calder was appointed as Director at Lunai Bioworks Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
James Sapirstein resigned as Director at Lunai Bioworks Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On October 12, 2024, James Sapirstein a member of the Board formally advised the Board of the Company that he was resigning from the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.5
James McNulty was appointed as Director at Lunai Bioworks Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Karen Brink resigned as Director at Lunai Bioworks Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On October 12, 2024, Karen Brink resigned as a director on the Board of the Company, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Carol Brosgart resigned as Director at Lunai Bioworks Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On October 13, 2024, Gregg Alton the Lead Independent Director on the Board, Jayne McNicol and Carol Brosgart formally advised the Board of the Company that they were resigning from the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.5
Mark Collins was appointed as Director at Lunai Bioworks Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ruud Hendriks resigned as Director at Lunai Bioworks Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On the same date, Ruud Hendriks resigned as a director on the Board of the Company, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jayne McNicol resigned as Director at Lunai Bioworks Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On October 13, 2024, Gregg Alton the Lead Independent Director on the Board, Jayne McNicol and Carol Brosgart formally advised the Board of the Company that they were resigning from the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.5
Maurice van Tilburg was appointed as Director at Lunai Bioworks Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Once Messrs. Weinstein, van Tilburg, McNulty, Calder and Collins’ Board committee membership is determined
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.